Colchicine compositions and methods

Details Colchicine compositions and methods Colchicine compositions and methods

2011-06-21

2011-06-21

Fetterolf, Brandon J (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C564S123000, C564S308000, C564S427000, C568S306000

Reexamination Certificate

active

07964647

ABSTRACT:
Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.

REFERENCES:
patent: 7601758 (2009-10-01), Davis
patent: 7619004 (2009-11-01), Davis
patent: 2005/0220877 (2005-10-01), Patel et al.
patent: 9215291 (1992-09-01), None
Leikin et al. Poisoning and toxicology handbook. Aug. 2007, p. 216.
Bodoki et al. Fast determination of colchicine by TLC-densitometry from pharmaceuticals and vegetal extracts. Journal of Pharmaceutical and Biomedical Analysis, 37, 2005: 971-977.
http://www.medsafe.govt.nz/Profs/PUArticles/colchicinetoxicity.htm.
Bombuwala et al. Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel. Beilstein Journal of Organic Chemistry, 2006, 2:13.
Leikin et al. Poisoning and toxicology handbook. Aug. 2007, pp. 216-217.
Wang et al. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharmaceutical Research, vol. 18, No. 6, pp. 800-806.
Horn et al., 2006, Pharmacy Times, pp. 111.
Wang et al. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharmaceutical Research, vol. 18, No. 6, pp. 800-806, 2001.
Jordan et al. “British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout (Full Guidelines)”, Rheumatology, 2007, pp. 1-17, Online Supplement to Jordan et al. 2007 “British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout (Executive Summary)”, Rheumatology (Oxford). Aug. 2007;46(8):1372-4. Epub May 23, 2007.
Zhang et al., “EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)”, Ann Rheum Dis 2006, 65: 1312-1324.
Ahern et al., “Does Colchicine Work? The results of the first controlled study in acute gout” Aust NZ J Med 1987; 17: 301-304.
Borstad, et al. “Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis” J Rheumatol 2004; 31:2429-32.
Morris, et al. “Lesson of the week—Colchicine in acute gout” BMJ 2003; 327:1275-6.
Paulus, et al. “Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients” Arthritis Rheum 1974, 17(5): 609-14.
Yurdakul et al. “A double-blind trial of colchicine in Behcet's syndrome” Arthritis Rheum. 2001, 44(11): 2686-2692.
Schlesinger et al. “Colchicine for acute gout”, Cochrane Database of Systematic Reviews, Issue 4, Oct. 18, 2006, pp. 1-18.
Ferron et al. “Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses” J. Clin. Pharmacol. 1996, 36: 874-883.
Girre et al. “Model-Independent Pharmacokinetics of Colchicine after Oral Administration to Healthy Volunteers” Fundam. Clin. Pharmacol. 1989, 3:537-543.
Achtert et al. “Pharmacokinetics/bioavailability of colchicine in healthy male volunteers” Eur. J. Drug Metab. Pharmacokinet. 1989, 14(4): 317-322.
Halkin et al. “Colchicine kinetics in patients with familial Mediterranean fever” Clin. Pharmacol. Ther. 1980, 28(1): 82-87.
Jiang et al. “Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of colchicine in human plasma” J. Chromatogr. B 2007, 850:564-568.
Korner & Kohn, “Development and optimization of a stability indicating method on a monolithic reversed-phase column for Colchicum dry extract” J. Chromatogr. A 2005, 1089:148-157.
Probenecid and Colchicine Tablets USP, Mar. 2006, Watson Laboratories product label.
Colchicine Tablets USP, 0.6 mg, Vison Pharma LLC product label, Oct. 2006.
CColchicine Tablets USP, Vintage Pharmaceuticals LLC (Qualitest) product label, Apr. 2005.
Colchicine Tablets USP, 0.6 mg, Akyma Pharmaceuticals LLC product label, Jan. 2005.
Colchicine Tablets USP, Feb. 2003, West-ward Pharmaceutical Corp. product label.
Terkeltaub “Gout” N Engl J Med 2003, 349: 1647-55.
Bombuwala, K. et al., Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel, Beilstein J. Org. Chem. 2006, 2:13, pp. 1-9.
“Colchicine Hydrate Product Data Sheet,” Tocris Bioscience, (2009).
“Dose” definition, Merriam Webster Online Medical Dictionary, downloaded from http://www.merriam-webster.com/medical/dose on Nov. 3, 2009.
Colchicine product data sheet, EMD Chemicals, Inc., downloaded from the internet on Oct. 5, 2009 from http://www.emdchemicals.com/life-science-research/colchicine-colchicum-autumnale/EMD—BIO-234115/p—Z—ab. s1L—9oAAAEWhmEfVhTm?WFSimpleSearch—NameOrID=colchicine&BackButtonText=search+results.

Affiliated with

Also associated with

Rating

Colchicine compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colchicine compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colchicine compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2745372